Surgical guidance firm, Mazor Robotics Ltd., advanced its strategic partnership with Medtronic plc, reported last year, ahead of schedule. As part of the agreement, Medtronic will take up distribution of the Mazor X surgical system, and commit a $40 million tranche investment in Mazor.

Channel Medsystems closed a series C-1 financing of $14.1 million led by insider investors. The company has developed a the Cerene physician-office cryotherapy device for heavy menstrual bleeding. Funds will be applied to efforts to seek FDA approval of the device, and for commercialization at a later date.